TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21167338

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Medical treatment (MED)
Number of subjects: 1000
Study: 18342223

Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg the day before (>or=15 h) and 600 mg the morning of the procedure (>or=2 h) (Group C)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Clopidogrel 300 mg the day before (>or=15 h) + 75 mg the morning of the procedure (Group A)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Clopidogrel 600 mg the morning of the procedure (>or=2 h) (Group B)
Number of subjects: 148
Study: 16552626

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NFT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 20
Study: 12651677

Group type: EXPERIMENTAL
Intervention: Epidural neostigmine (4 microg/kg) combined with ropivacaine 0.1%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural neostigmine (4 microg/kg) combined with ropivacaine 0.1% and sufentanil 10 microg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia with ropivacaine 0.1%
Number of subjects: 0
Study: 10881260

Group type: EXPERIMENTAL
Intervention: Enhancement of low, middle, or high facial frequency information (cycles per face) through presentation of photographs of unfamiliar faces.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low facial frequency information (cycles per face)
Number of subjects: 0
Study: 9255192

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) with conventional ventilation
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Crossover treatment with iNO after HFOV failure
Number of subjects: 205

Group type: COMPARATOR
Intervention: Crossover treatment with HFOV after iNO failure
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Combination treatment with HFOV plus iNO
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Either treatment alone or combination therapy
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: HFOV plus iNO in respiratory distress syndrome and meconium aspiration syndrome
Number of subjects: 205

Group type: COMPARATOR
Intervention: Overall outcomes across centers
Number of subjects: 205
Study: 8509981

Group type: EXPERIMENTAL
Intervention: Zidovudine (Protocol 019)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Protocol 019
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control
Number of subjects: 73
Study: 3625231

Group type: EXPERIMENTAL
Intervention: Intravenous therapy with murine antimelanoma monoclonal antibody 9.2.27, 500 mg dose
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Single 2 h infusion of 500 mg of 9.2.27
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Five daily 2 h infusions of 100 mg of 9.2.27
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Interruption in therapy for 4 weeks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Initial infusions of 500 mg of 9.2.27
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Monitoring antiglobulin levels during therapy
Number of subjects: 13
Study: 31974286

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.5 meq/kg lean body wt per day; n=35)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (n=39)
Number of subjects: 74
Study: 31547827

Group type: EXPERIMENTAL
Intervention: Artesunate-mefloquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primaquine (0.5 mg/kg/day for 7-9 days)
Number of subjects: 0
Study: 28962948

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CCRT) with thoracic radiotherapy (50 Gy in 25 fractions) and five cycles of weekly paclitaxel (50 mg/m2) and cisplatin (25 mg/m2), followed by two additional cycles of paclitaxel (175 mg/m2) plus cisplatin (80 mg/m2) at 3-week intervals.
Number of subjects: 101

Group type: COMPARATOR
Intervention: Chemotherapy with four cycles of adjuvant paclitaxel (175 mg/m2) and carboplatin (AUC = 5.5) every 3 weeks.
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: CCRT
Number of subjects: 101

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 101
Study: 25712944

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target systolic blood pressure <140 mm Hg)
Number of subjects: 1310

Group type: COMPARATOR
Intervention: Guideline-based blood pressure management (systolic blood pressure <180 mm Hg)
Number of subjects: 1310
Study: 23231426

Group type: EXPERIMENTAL
Intervention: Video Laryngoscopy (VL)
Number of subjects: 858

Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 858
Study: 21390165

Group type: EXPERIMENTAL
Intervention: Fentanyl 20 µg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Sufentanil 2.5 µg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (0.5% hyperbaric bupivacaine only)
Number of subjects: 72
Study: 20032609

Group type: EXPERIMENTAL
Intervention: Bethanechol administration during radiotherapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Artificial saliva (control)
Number of subjects: 36
Study: 18693589

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC‐40) 40 mg instilled within 30 minutes of TUR
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (TUR only)
Number of subjects: 75
Study: 15010178

Group type: EXPERIMENTAL
Intervention: Consume MSG+
Number of subjects: 113

Group type: COMPARATOR
Intervention: Consume MSG‐
Number of subjects: 113

Group type: COMPARATOR
Intervention: Taste MSG+
Number of subjects: 113
Study: 12530552

Group type: EXPERIMENTAL
Intervention: EPA
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: DHA
Number of subjects: 33

Group type: COMPARATOR
Intervention: Safflower oil
Number of subjects: 33
Study: 9440666

Group type: EXPERIMENTAL
Intervention: Olestra potato chips
Number of subjects: 1123

Group type: COMPARATOR
Intervention: Regular TG potato chips
Number of subjects: 1123
Study: 7532056

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no G-CSF)
Number of subjects: 42
Study: 2547916

Group type: EXPERIMENTAL
Intervention: Fish oil containing eicosapentaenoic acid and docosahexaenoic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fish oil treatment
Number of subjects: 0
Study: 1093633

Group type: EXPERIMENTAL
Intervention: Miconazole nitrate
Number of subjects: 69

Group type: COMPARATOR
Intervention: Chlordantoin
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Miconazole nitrate (after second course)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Chlordantoin (after second course)
Number of subjects: 69
Study: 310412

Group type: EXPERIMENTAL
Intervention: Gastrozepin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indometacin
Number of subjects: 0
Study: 31006545

Group type: EXPERIMENTAL
Intervention: Probiotic (Ultrabiotic 60™ and SB Floractiv™ 250 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 28125624

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 90
Study: 25601978

Group type: EXPERIMENTAL
Intervention: Repeat antenatal betamethasone
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo (single course)
Number of subjects: 258
Study: 23699515

Group type: EXPERIMENTAL
Intervention: Double-pulse transcranial magnetic stimulation (dpTMS) during resting state
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Double-pulse transcranial magnetic stimulation (dpTMS) during event-related condition
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Double-pulse transcranial magnetic stimulation (dpTMS)
Number of subjects: 64
Study: 21366974

Group type: EXPERIMENTAL
Intervention: Post-operative whole breast irradiation (RT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omission of RT
Number of subjects: 0
Study: 19336728

Group type: EXPERIMENTAL
Intervention: Bicalutamide 50 mg/wk
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bicalutamide 100 mg/wk
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bicalutamide (both doses)
Number of subjects: 80
Study: 17899572

Group type: EXPERIMENTAL
Intervention: Progesterone vaginal gel
Number of subjects: 659

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 659
Study: 15514398

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 11916619

Group type: EXPERIMENTAL
Intervention: Antibiotic-soak group (gentamicin solution for approximately 2 min)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (standard implantation procedure)
Number of subjects: 186
Study: 9785777

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol and fentanyl (group P, n = 107)
Number of subjects: 211

Group type: COMPARATOR
Intervention: General anesthesia with thiopental, sevoflurane and nitrous oxide (group TS, n = 104)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol and fentanyl (group P)
Number of subjects: 211

Group type: COMPARATOR
Intervention: General anesthesia with thiopental, sevoflurane and nitrous oxide (group TS)
Number of subjects: 211
Study: 7630982

Group type: EXPERIMENTAL
Intervention: High ability with difficult task standard
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low ability with easy task standard
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low ability with low task standard
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High ability with high task standard
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood pressure reactivity
Number of subjects: 0
Study: 2715803

Group type: EXPERIMENTAL
Intervention: MOPP chemotherapy (CT) - six courses
Number of subjects: 89

Group type: COMPARATOR
Intervention: Mantle plus lumbar bar radiotherapy (RT) - 36‐45 Gy
Number of subjects: 89
Study: 1052105

Group type: EXPERIMENTAL
Intervention: Tinidazole (Fasigyn-Pfizer) - 2 grammes as a single oral dose
Number of subjects: 28

Group type: COMPARATOR
Intervention: Yeast (Placebo)
Number of subjects: 28
Study: 31524770

Group type: EXPERIMENTAL
Intervention: Branched-chain amino acid-enriched nutrient (12.2 g of branched-chain amino acid, 410 kcal, half consumed as a late evening snack)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Branched-chain amino acid granules (12 g of branched-chain amino acid)
Number of subjects: 26
Study: 30904771

Group type: EXPERIMENTAL
Intervention: Amadeo™ hand training (AHT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional hand training (CHT)
Number of subjects: 50
Study: 28165578

Group type: EXPERIMENTAL
Intervention: Training on 2.5-mm diameter simulated vessel
Number of subjects: 51

Group type: COMPARATOR
Intervention: Training on 5-mm diameter simulated vessel
Number of subjects: 51
Study: 26964162

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with rehabilitation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Optimal acupuncture manipulation plan at the early stage: deep acupuncture and oblique insertion for 20 min with zero-time manipulation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Optimal acupuncture manipulation plan at the later stage: deep acupuncture and oblique insertion for 20 min with three-time manipulation
Number of subjects: 90
Study: 24195203

Group type: EXPERIMENTAL
Intervention: Acupuncture‐moxibustion group
Number of subjects: 111

Group type: COMPARATOR
Intervention: Elongated needle group
Number of subjects: 111

Group type: COMPARATOR
Intervention: Herb‐partitioned moxibustion group
Number of subjects: 111
Study: 21288838

Group type: EXPERIMENTAL
Intervention: Doxycycline-containing regimens
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Azithromycin-containing regimens
Number of subjects: 305

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 305

Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 305
Study: 19688135

Group type: EXPERIMENTAL
Intervention: Endoscopic transsphenoidal approach
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sublabial microscopic approach
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Higher grade of invasiveness
Number of subjects: 50
Study: 17015192

Group type: EXPERIMENTAL
Intervention: 'fast track' open verum homeopathy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 'fast track' double‐blind verum homeopathy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 'fast track' double‐blind placebo homeopathy
Number of subjects: 75

Group type: COMPARATOR
Intervention: waiting list control
Number of subjects: 75
Study: 15472858

Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 649

Group type: COMPARATOR
Intervention: Zidovudine combined with lamivudine and efavirenz
Number of subjects: 649
Study: 12596653

Group type: EXPERIMENTAL
Intervention: Mebendazole (100 mg twice a day for three consecutive days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mebendazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Albendazole
Number of subjects: 0
Study: 9829028

Group type: EXPERIMENTAL
Intervention: SSRIs (selective serotonin reuptake inhibitors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antipsychotic augmentations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monoamine oxidase inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behaviour therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neurosurgery
Number of subjects: 0
Study: 8078530

Group type: EXPERIMENTAL
Intervention: Budesonide (9 mg per day for 8 weeks, then 6 mg per day for 2 weeks)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Prednisolone (40 mg per day for 2 weeks, then gradually reduced to 5 mg per day)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 176

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Budesonide and Prednisolone
Number of subjects: 176
Study: 2635498

Group type: EXPERIMENTAL
Intervention: Piracetam and Ergotoxin
Number of subjects: 5
Study: 829223

Group type: EXPERIMENTAL
Intervention: Local thiotepa chemotherapy after TUR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local VM 26 chemotherapy after TUR
Number of subjects: 0

Group type: COMPARATOR
Intervention: TUR only
Number of subjects: 0
Study: 30779960

Group type: EXPERIMENTAL
Intervention: Team-based outpatient palliative care (PC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 29702222

Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 153
Study: 27612212

Group type: EXPERIMENTAL
Intervention: Vertical vaginal cuff closure technique (group 1)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Horizontal vaginal cuff closure technique (group 2)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Overall results for both groups
Number of subjects: 78
Study: 24557812

Group type: EXPERIMENTAL
Intervention: Functional movement circle (FuMoC) training for 12 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Usual activities (control group)
Number of subjects: 21
Study: 21587111

Group type: EXPERIMENTAL
Intervention: Total Disc Arthroplasty (TDA)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Anterior Cervical Fusion (ACDF)
Number of subjects: 170
Study: 20056684

Group type: EXPERIMENTAL
Intervention: Multicomponent psychosocial intervention
Number of subjects: 0
Study: 17393216

Group type: EXPERIMENTAL
Intervention: 8 g/day DHA-rich fish oil
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 4 g/day DHA-rich fish oil
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil (both dosages)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 45
Study: 15731398

Group type: EXPERIMENTAL
Intervention: Resistance training for 3 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detraining after resistance training for 3 months
Number of subjects: 0
Study: 12499748

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Open appendectomy (OA)
Number of subjects: 45
Study: 10413345

Group type: EXPERIMENTAL
Intervention: MRI diagnosis of hard disc
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: MRI diagnosis of soft disc
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: MRI in elderly patients
Number of subjects: 41
Study: 8534465

Group type: EXPERIMENTAL
Intervention: Fentanyl 100 micrograms IV
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dezocine 6 mg IV
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg IV
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 80
Study: 2257958

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 7003457

Group type: EXPERIMENTAL
Intervention: Levamisole (50 mg t.i.d. for 3 consecutive days every 2 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 24
Study: 31698138

Group type: EXPERIMENTAL
Intervention: Restricted housing vouchers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional public housing
Number of subjects: 0
Study: 31270173

Group type: EXPERIMENTAL
Intervention: MenB vaccine (Bexsero)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Historical MenB study (20 adults)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Other meningococcal vaccines (57 adults)
Number of subjects: 120
Study: 28027445

Group type: EXPERIMENTAL
Intervention: Osteopathic treatment coupled with usual lactation consultations
Number of subjects: 97

Group type: COMPARATOR
Intervention: Usual lactation consultations (Control)
Number of subjects: 97
Study: 26391602

Group type: EXPERIMENTAL
Intervention: 4.8 g/day oral mesalazine
Number of subjects: 112

Group type: COMPARATOR
Intervention: 2.4 g/day oral mesalazine
Number of subjects: 112
Study: 24342265

Group type: EXPERIMENTAL
Intervention: Media Smart program
Number of subjects: 540

Group type: COMPARATOR
Intervention: Control group (normal lessons)
Number of subjects: 540
Study: 23206372

Group type: EXPERIMENTAL
Intervention: Two-phase treatment starting in mixed dentition
Number of subjects: 65

Group type: COMPARATOR
Intervention: One-phase treatment during adolescent dentition
Number of subjects: 65
Study: 19237900

Group type: EXPERIMENTAL
Intervention: NIV with high internal volume mask (977 mL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: NIV with moderate internal volume mask (84 mL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: NIV with low internal volume mask (163 mL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: NIV with mouthpiece (virtually no internal volume)
Number of subjects: 14
Study: 17478385

Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rupatadine 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg and 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rupatadine 5 mg
Number of subjects: 0
Study: 15204222

Group type: EXPERIMENTAL
Intervention: Involuntarily admitted patients treated without locking the doors of the wards
Number of subjects: 444

Group type: COMPARATOR
Intervention: Committed and voluntarily admitted patients
Number of subjects: 444

Group type: COMPARATOR
Intervention: Patients and relatives
Number of subjects: 444
Study: 12217902

Group type: EXPERIMENTAL
Intervention: 20-kDa GH in normal subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20-kDa GH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin, androgen, and oral estrogen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant 22-kDa GH
Number of subjects: 0
Study: 9524780

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (PUFA) supplementation (5.2 g daily for 12 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo oil (olive oil) supplementation (5.2 g daily for 12 weeks)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: n-3 PUFA content in cell membranes
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Baseline HRV measurement
Number of subjects: 29
Study: 7642755

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no relaxation training)
Number of subjects: 16
Study: 1519166

Group type: EXPERIMENTAL
Intervention: Glycerol (220 gm)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Glucose (320 gm)
Number of subjects: 22
Study: 6685641

Group type: EXPERIMENTAL
Intervention: Prior endocrine therapy responders
Number of subjects: 104

Group type: COMPARATOR
Intervention: Prior endocrine therapy non-responders
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Non-responders with stable disease
Number of subjects: 104
Study: 31474607

Group type: EXPERIMENTAL
Intervention: High-flow oxygen
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 268

Group type: COMPARATOR
Intervention: T-tube
Number of subjects: 268
Study: 29179024

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (10 min)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation (10 min)
Number of subjects: 118

Group type: COMPARATOR
Intervention: No-instruction control condition
Number of subjects: 118
Study: 27492833

Group type: EXPERIMENTAL
Intervention: Aclidinium/formoterol 400/12 µg twice-daily
Number of subjects: 933

Group type: COMPARATOR
Intervention: Salmeterol/fluticasone 50/500 µg twice-daily
Number of subjects: 933